PlainRecalls
FDA Drug Moderate Class II Terminated

Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90

Reported: October 23, 2019 Initiated: September 4, 2019 #D-0145-2020

Product Description

Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90

Reason for Recall

CGMP Deviation: Presence of dark brown discoloration on edges of tablets.

Details

Units Affected
63,216 bottles
Distribution
Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 63,216 bottles.
Why was this product recalled?
CGMP Deviation: Presence of dark brown discoloration on edges of tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 23, 2019. Severity: Moderate. Recall number: D-0145-2020.